Mutum CYP2C19 Gene Polymorphism

Takaitaccen Bayani:

Ana amfani da wannan kit ɗin don gano ƙimar ingancin in vitro na polymorphism na CYP2C19 genes CYP2C19*2 (rs4244285, c.681G>A), CYP2C19 * 3 (rs4986893, c.636G>A), CYP2C19*26 (rs4244285) > T) a cikin kwayar halittar DNA na samfuran jinin mutum gaba daya.


Cikakken Bayani

Tags samfurin

Sunan samfur

HWTS-GE012A-Human CYP2C19 Gene Polymorphism Gane Kit (Fluorescence PCR)

Takaddun shaida

CE

Epidemiology

CYP2C19 yana ɗaya daga cikin mahimman ƙwayoyin metabolizing magunguna a cikin dangin CYP450.Mutane da yawa endogenous substrates da kuma game da 2% na asibiti kwayoyi suna metabolized ta CYP2C19, kamar metabolism na antiplatelet tara inhibitors (kamar clopidogrel), proton famfo inhibitors (omeprazole), anticonvulsants, da dai sauransu CYP2C19 gene polymorphisms kuma suna da bambance-bambance a cikin metabolizing ikon metabolizing. kwayoyi masu alaka.Wadannan maye gurbi na * 2 (rs4244285) da * 3 (rs4986893) suna haifar da asarar aikin enzyme wanda aka sanya ta hanyar CYP2C19 gene da raunin ƙarfin substrate na rayuwa, kuma yana ƙaruwa da maida hankali na jini, don haifar da mummunan halayen ƙwayoyi masu alaƙa. maida hankali na jini.* 17 (rs12248560) na iya ƙara yawan aikin enzyme da aka sanya ta hanyar CYP2C19 gene, samar da metabolites masu aiki, da haɓaka haɓakar haɓakar platelet da haɓaka haɗarin zub da jini.Ga mutanen da ke da jinkirin metabolism na kwayoyi, yin amfani da allurai na al'ada na dogon lokaci zai haifar da mummunar guba da sakamako masu illa: yawanci lalacewar hanta, lalacewar tsarin hematopoietic, lalacewar tsarin juyayi na tsakiya, da dai sauransu, wanda zai iya haifar da mutuwa a lokuta masu tsanani.Dangane da bambance-bambancen mutum a cikin metabolism miyagun ƙwayoyi, an raba shi zuwa cikin phenotypes huɗu, um, * 17 / * 1 / * 1 ) , matsakaicin metabolism (IM, *1/*2, *1/*3), jinkirin metabolism (PM, *2/*2, *2/*3, *3/*3).

Tashoshi

FAM Saukewa: CYP2C19*2
CY5 CYP2C9*3
ROX CYP2C19*17
VIC/HEX IC

Ma'aunin Fasaha

Adana Ruwa: ≤-18℃
Rayuwar rayuwa watanni 12
Nau'in Samfura Fresh EDTA anticoagulated jini
CV ≤5.0%
LoD 1.0ng/μL
Musamman Babu wani giciye-reactivity tare da wasu daidaitattun jeri (CYP2C9 gene) a cikin kwayoyin halittar dan adam.Maye gurbi na CYP2C19*23, CYP2C19*24 da CYP2C19*25 a waje da kewayon gano wannan kit ɗin ba su da wani tasiri akan tasirin gano wannan kit ɗin.
Abubuwan da ake Aiwatar da su Abubuwan da aka Aiwatar da Biosystems 7500 Tsarin PCR na Gaskiya

Abubuwan da aka Aiwatar da Tsarin Halittu 7500 Tsarin PCR Mai Saurin Real-Time

QuantStudio®5 Tsarin PCR na Gaskiya

SLAN-96P Tsarin PCR na Gaskiya

LightCycler®480 Tsarin PCR na Gaskiya

LineGene 9600 Plus Tsarin Gane PCR na Gaskiya

MA-6000 Mai ƙididdige yawan zafin jiki na ainihi

BioRad CFX96 Tsarin PCR na Gaskiya

BioRad CFX Opus 96 Tsarin PCR na Gaskiya

Gudun Aiki

Nasihar hakar reagent:Macro & Micro-Test Viral DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48, HWTS-3004-96) da Macro & Micro-Test Atomatik Nucleic Acid Extractor (HWTS-3006).


  • Na baya:
  • Na gaba:

  • Ku rubuta sakonku anan ku aiko mana